Skip to content
  1. Growing Investment in Robotics Companies – Investors continue funding the latest robotics innovations in various industries, including the medical, manufacturing, logistics, hospitality, and automotive sectors. With plenty of cash in the market, venture capital (VC), private equity (PE), and strategic investors aim to capitalize on and steer development of disruptive robotics technologies.
  2. Intellectual Property (IP) Is Critical for Robotics Innovations – Patents and trade secrets continue to be essential tools for protecting robotics innovations and maintaining a competitive edge. Strategic companies will increasingly leverage design patents to protect the “look and feel” of robots and user interfaces in addition to the “how it works” protections afforded by utility patents.
  3. Cobots Take Center Stage in the Workplace – Many companies dream of full automation, but the reality is there are many tasks robots just can’t perform as well as humans at this stage. Cobots (robots that work alongside humans) will help bridge the automation gap as developers continue efforts to perfect robotic artificial intelligence (AI). Companies will also look to cobots to help smooth the transition of integrating robot platforms into their operations.
  4. Progress in Robot Interoperability – As companies adopt robotic platforms from multiple developers, these diverse platforms need to be able to communicate and work together. This interoperability, which is similar to standard setting and interoperability pushes in analogous tech industries (e.g., computers, telecom), is expected to become more prevalent as robotics adoption becomes more widespread.
  5. Increased Efforts to Prevent Hacking and Mitigate Liability – Hacking will continue to be a top concern for the robotics industry as hackers taking control of robots could cause significant damage, disruption, and even bodily harm. Questions of liability also arise in this context, which also are driving an intensive push by industry and government to head off evolving threats.
Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Todd Basile Todd Basile

Todd helps technology companies and investors protect and commercialize their innovations across a wide range of industries including software, robotics, autonomous vehicles, medical devices, and aerospace.

His practice offers a full suite of IP-related legal services including:

  • Patents – Developing portfolios tailored to

Todd helps technology companies and investors protect and commercialize their innovations across a wide range of industries including software, robotics, autonomous vehicles, medical devices, and aerospace.

His practice offers a full suite of IP-related legal services including:

  • Patents – Developing portfolios tailored to your company’s particular goals such as attracting investment, protecting market share, or having bargaining chips in disputes with competitors
  • M&A and Investment – Helping investors understand what they are buying and mitigating the associated risks; helping sellers position their technology assets to maximize company valuation and attract (and close) funding opportunities
  • Tech Transactions – Negotiating partnerships to grow the company, while protecting your IP and technology and minimizing business disruption should future problems arise
  • Freedom to Operate – Guiding product design to avoid infringing third-party patent rights
  • Software Development & Licensing – Navigating the numerous software-related legal issues such as ownership, subscription licensing (SaaS), control, data privacy and security, source code escrow, and open source software (OSS) risks

Prior to becoming an attorney, Todd was an engineer at Bell Helicopter where he designed cutting-edge aerospace technologies and software. Todd also helped develop electromechanical control systems for military drones at Smiths Aerospace during his undergraduate studies at Georgia Tech, and clerked at St. Jude Medical’s Neuromodulation Division during law school.

Photo of David J. Dykeman David J. Dykeman

David Dykeman, who serves as Co-Managing Shareholder of Greenberg Traurig’s Boston office and co-chairs the firm’s global Life Sciences & Medical Technology Group, is a registered patent attorney with more than 22 years of experience in patent and intellectual property law. David’s practice

David Dykeman, who serves as Co-Managing Shareholder of Greenberg Traurig’s Boston office and co-chairs the firm’s global Life Sciences & Medical Technology Group, is a registered patent attorney with more than 22 years of experience in patent and intellectual property law. David’s practice focuses on securing worldwide intellectual property protection and related business strategy for high tech clients, with particular experience in life sciences, medical devices, robotics, materials, and information technology.

David provides strategic patent portfolio development and intellectual property advice for clients including major research institutions, multi-national corporations, and start-up companies. He also performs patent due diligence to assess patent portfolios for venture capital investment, mergers and acquisitions, and licensing opportunities.

An author of over 50 articles and a speaker at over 45 conferences on intellectual property law, David is the founding co-chair of the ABA’s Medical Devices Committee. He was honored as one of Boston’s “40 Under 40” innovative business leaders by the Boston Business Journal and was named to the “40 Medtech Innovators Under 40” list by Medical Device & Diagnostic Industry (MD+DI) Magazine. David has also been named one of the top 250 Patent and Technology Licensing Practitioners in the world by Intellectual Asset Management (IAM) Magazine, an “IP Star” by Managing IP magazine, a “Life Science Star” by LMG Life Sciences, and one of the World’s Leading IP Strategists in the IAM 300.

Photo of Roman Fayerberg Roman Fayerberg

Roman Fayerberg is a registered patent attorney with broad experience helping clients to strategically protect and leverage their innovations globally. Roman works with clients to develop and manage worldwide patent portfolios and counsels clients in regard to freedom to operate, patent landscape, and…

Roman Fayerberg is a registered patent attorney with broad experience helping clients to strategically protect and leverage their innovations globally. Roman works with clients to develop and manage worldwide patent portfolios and counsels clients in regard to freedom to operate, patent landscape, and patent infringement and validity matters. He also conducts and defends patent due diligence investigations in connection with venture capital investments, mergers and acquisitions, and licensing opportunities.

Roman has represented clients ranging from start-ups to global companies in a variety of technical areas, including medical devices, robotics, diagnostic and imaging systems, microfluidic devices, and biotechnology. He understands the legal goals of each of his clients and develops and executes patent strategies that meet such goals.